M&A Deal Summary |
|
|---|---|
| Date | 2021-02-17 |
| Target | Cognate BioServices |
| Sector | Life Science |
| Buyer(s) | Charles River Laboratories International |
| Sellers(s) |
Tennenbaum Capital Partners
Medivate Partners EW Healthcare Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 875M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1947 |
| Sector | Life Science |
| Employees | 20,400 |
| Revenue | 4.1B USD (2023) |
Charles River Laboratories International is a provider of essential products and contract services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Charles River Laboratories International was incorporated in 1947 and is based in Wilmington, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 27 of 31 |
| Sector (Life Science) | 24 of 28 |
| Type (Add-on Acquisition) | 22 of 26 |
| State (Tennessee) | 1 of 1 |
| Country (United States) | 17 of 20 |
| Year (2021) | 2 of 4 |
| Size (of disclosed) | 2 of 17 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-01-04 |
Distributed Bio
South San Francisco, California, United States Based in South San Francisco, California, Distributed Bio is a next-generation antibody discovery company. Distributed Bio’s SuperHuman antibody libraries and integrated antibody optimization technologies help to enhance the probability of success for delivering high-quality, readily formattable antibody fragments to support antibody and cell and gene therapy candidates to biopharmaceutical clients. Distributed Bio’s libraries are computationally optimized for both sequence diversity and immuno-engineering fitness through the analysis of thousands of human antibody repertoires and all known monoclonal therapeutics in clinical trials, which can generate many unique binders against every antigen tested. This large molecule discovery platform improves the chance of successful hit finding, reduces optimization requirements, and thereby expedites the antibody discovery process by several months. Distributed Bio’s computational immunology expertise also enables optimization of existing client antibodies generated through more traditional platforms, such as hybridoma or traditional phage display. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-31 |
Retrogenix
Chinley, United Kingdom Retrogenix is an early-stage contract research organization (CRO) providing specialized bioanalytical services utilizing its proprietary cell microarray technology. Retrogenix is based in Chinley, United Kingdom. |
Buy | £35M |
| Category | Asset Manager |
|---|---|
| Founded | 1999 |
| PE ASSETS | 18.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Tennenbaum Capital Partners is a private investment group focused on providing financing solutions to middle-market companies in a variety of sectors. The Firm separates its activity into two segments - performing and distressed. The performing group looks to invest $10 to $125 million to support recapitalizations, LBOs, acquisitions, and growth capital needs of companies valued between $100 million and $1.5 billion. The special situations group looks to provide $20 to $125 million to support rescue needs, as well as fund complex situations or secondary market purchases. Tennenbaum primarily considers opportunities in North America and Europe, but will consider other geographies. Tennenbaum Capital Partners was formed in 1999 and is based in Santa Monica, California.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 9 |
| Sector (Life Science) | 1 of 1 |
| Type (Add-on Acquisition) | 5 of 5 |
| State (Tennessee) | 1 of 1 |
| Country (United States) | 8 of 8 |
| Year (2021) | 1 of 1 |
| Size (of disclosed) | 1 of 4 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-12-12 |
Hanley Wood
Washington, District of Columbia, United States Hanley Wood is a media and information company serving the housing and commercial design and construction industries. Hanley Wood provides magazines and Web sites, marquee trade shows and events, market intelligence data and custom marketing solutions. Hanley Wood was founded in 1976 and is based in Washington. District of Columbia. |
Sell | - |
Medivate Partners is a private equity and venture capital firm focused on investment in the biotech/healthcare industry. The Firm looks will consider companies throughout Asia and North America and has a particular interest in businesses that can capitalize on cross border opportunities. Medivate Partners was established in 2012 and is headquartered in Seoul.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector (Life Science) | 1 of 2 |
| Type (Add-on Acquisition) | 1 of 2 |
| State (Tennessee) | 1 of 1 |
| Country (United States) | 1 of 2 |
| Year (2021) | 1 of 2 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-02-20 |
Cognate BioServices
Memphis, Tennessee, United States Cognate BioServices, Inc. is a fully-integrated contract bioservices organization that provides a systematic level of scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development and manufacture of cell-based products. Cognate BioServices was founded in 2002 and is based in Memphis, Tennessee. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-02-19 |
WCCT Global
Cypress, California, United States WCCT Global LLC is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. WCCT Global is based in Cypress, California. |
Sell | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1985 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.
| DEAL STATS | # |
|---|---|
| Overall | 52 of 53 |
| Sector (Life Science) | 17 of 17 |
| Type (Add-on Acquisition) | 33 of 34 |
| State (Tennessee) | 1 of 2 |
| Country (United States) | 45 of 46 |
| Year (2021) | 2 of 3 |
| Size (of disclosed) | 1 of 22 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-02-04 |
Bioventus
Durham, North Carolina, United States Bioventus provides clinical and cost-effective therapies and diagnostics to help patients regain active lifestyles. The company's innovative products include bone stimulation devices and osteoarthritis joint fluid therapies. Bioventus was incorporated in 2011 and is based in Durham, North Carolina. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-03-12 |
BreatheAmerica
Nashville, Tennessee, United States BreatheAmerica develops and operates diagnostic and treatment centers for chronic airway and immune system-related diseases. Through its allergy, sinus and asthma programs and immune therapy programs, BreatheAmerica centers concentrate the resources needed to diagnose and care for these interrelated and complex diseases that affect 25% of the country’s population. BreatheAmerica is based in Nashville, Tennessee. |
Sell | - |
